Yargesa
NDC 42799-709, Miglustat, capsule, from Edenbridge Pharmaceuticals LLC..
- Product NDC
- 42799-709
- Status
- Listed
- Labeler
- Edenbridge Pharmaceuticals LLC.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209821
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42799-709 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MIGLUSTAT100 mg/1
Pharmacologic classes
Enzyme Stabilizer [EPC]; Enzyme Stabilizers [MoA]; Glucosylceramide Synthase Inhibitor [EPC]; Glucosylceramide Synthase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42799-709-15 | 42799070915 | 1 BLISTER PACK in 1 CARTON (42799-709-15) / 15 CAPSULE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2b371dfe-e2b0-47fe-b677-a7bde7149f87
Use it
Look up 42799-709 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42799-709 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42799-709. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.